Literature DB >> 12606511

Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content.

Mirja Tiikkainen1, Robert Bergholm, Satu Vehkavaara, Aila Rissanen, Anna-Maija Häkkinen, Marjo Tamminen, Kari Teramo, Hannele Yki-Järvinen.   

Abstract

Our objective was to determine how 8% weight loss influences subcutaneous, intra-abdominal, and liver fat (LFAT), as well as features of insulin resistance, in obese women with high versus low LFAT. A total of 23 women with previous gestational diabetes were divided into groups of high (9.4 +/- 1.4%) and low (3.3 +/- 0.4%) LFAT based on their median LFAT (5%) measured with proton spectroscopy. Both groups were similar with respect to age, BMI, and intra-abdominal and subcutaneous fat. Before weight loss, women with high LFAT had higher fasting serum insulin and triglyceride concentrations than women with low LFAT. At baseline, LFAT correlated with the percent of fat (r = 0.44, P < 0.05) and saturated fat (r = 0.45, P < 0.05) of total caloric intake but not intra-abdominal or subcutaneous fat or fasting serum free fatty acids. Weight loss was similar between the groups (high LFAT -7.4 +/- 0.2 vs. low LFAT -7.7 +/- 0.3 kg). LFAT decreased from 9.4 +/- 1.4 to 4.8 +/- 0.7% (P < 0.001) in women with high LFAT and from 3.3 +/- 0.4 to 2.0 +/- 0.2% (P < 0.001) in women with low LFAT. The absolute decrease in LFAT was significantly higher in women with high than low LFAT (-4.6 +/- 1.0 vs. -1.3 +/- 0.3%, P < 0.005). The decrease in LFAT was closely correlated with baseline LFAT (r = -0.85, P < 0.001) but not with changes in the volumes of intra-abdominal or subcutaneous fat depots, which decreased similarly in both groups. LFAT appears to be related to the amount of fat in the diet rather than the size of endogenous fat depots in obese women. Women with initially high LFAT lost more LFAT by similar weight loss than those with low LFAT, although both groups lost similar amounts of subcutaneous and intra-abdominal fat. These data suggest that LFAT is regulated by factors other than intra-abdominal and subcutaneous fat. Therefore, LFAT does not appear to simply reflect the size of endogenous fat stores.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606511     DOI: 10.2337/diabetes.52.3.701

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  73 in total

Review 1.  Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds.

Authors:  Konstantinos Michalakis; Carel le Roux
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

2.  Elevation of alanine transaminase and markers of liver fibrosis after a mixed meal challenge in individuals with type 2 diabetes.

Authors:  E Y H Khoo; M C Stevenson; E Leverton; R Cross; J W Eriksson; S M Poucher; I Spendlove; P G Morris; I A Macdonald; P Mansell; G P Aithal
Journal:  Dig Dis Sci       Date:  2012-05-17       Impact factor: 3.199

3.  Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging.

Authors:  Roy Irwan; Mireille A Edens; Paul E Sijens
Journal:  Eur Radiol       Date:  2007-11-13       Impact factor: 5.315

4.  Reproducibility of single- and multi-voxel 1H MRS measurements of intramyocellular lipid in overweight and lean subjects under conditions of controlled dietary calorie and fat intake.

Authors:  Wei Shen; Xiangling Mao; Carla Wolper; Stanley Heshka; Stephen Dashnaw; Joy Hirsch; Steven B Heymsfield; Dikoma C Shungu
Journal:  NMR Biomed       Date:  2008-06       Impact factor: 4.044

Review 5.  Pharmacological agents for NASH.

Authors:  Vlad Ratziu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-10-15       Impact factor: 46.802

Review 6.  Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis.

Authors:  C Merlotti; V Ceriani; A Morabito; A E Pontiroli
Journal:  Int J Obes (Lond)       Date:  2017-02-02       Impact factor: 5.095

7.  Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects.

Authors:  D Enette Larson-Meyer; Leonie K Heilbronn; Leanne M Redman; Bradley R Newcomer; Madlyn I Frisard; Steve Anton; Steven R Smith; Anthony Alfonso; Eric Ravussin
Journal:  Diabetes Care       Date:  2006-06       Impact factor: 19.112

8.  Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects.

Authors:  Kristina M Utzschneider; Jennifer L Bayer-Carter; Matthew D Arbuckle; Jaime M Tidwell; Todd L Richards; Suzanne Craft
Journal:  Br J Nutr       Date:  2012-07-31       Impact factor: 3.718

9.  Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans.

Authors:  N Stefan; A Peter; A Cegan; H Staiger; J Machann; F Schick; C D Claussen; A Fritsche; H-U Häring; E Schleicher
Journal:  Diabetologia       Date:  2008-02-20       Impact factor: 10.122

10.  Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.

Authors:  Mariana Lazo; Steven F Solga; Alena Horska; Susanne Bonekamp; Anna Mae Diehl; Frederick L Brancati; Lynne E Wagenknecht; F Xavier Pi-Sunyer; Steven E Kahn; Jeanne M Clark
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.